MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling
Cited by 159
Related Papers
Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6/STAT3 signaling pathway
|Oncotarget|2017|221
Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer
|British Journal of Cancer|2020|60
miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma
|Oncotarget|2017|55
Effects and mechanisms of fatty acid metabolism‑mediated glycolysis regulated by betulinic acid‑loaded nanoliposomes in colorectal cancer
|Oncology Reports|2020|19
SMURF1 attenuates endoplasmic reticulum stress by promoting the degradation of KEAP1 to activate NRF2 antioxidant pathway
|Cell Death and Disease|2023|18